Intraocular drug delivery systems

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/34 (2006.01) A61F 2/14 (2006.01) A61K 9/00 (2006.01) A61K 9/10 (2006.01) A61K 9/16 (2006.01) A61K 31/498 (2006.01) A61K 31/565 (2006.01) A61M 31/00 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2670746

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants such as microsheres provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer. The active is selected from estradiols such as 2-methoxyestradiol or alpha 2. adrenergic agonists such as brimonidine and its derivates or prostagladin analogis.

La présente invention concerne des implants biodégradables et adaptés pour être implantés dans une région ou un site oculaire. L'invention concerne également des procédés de traitement de pathologies oculaires. Lesdits implants assurent la libération prolongée d'un agent actif en une quantité thérapeutiquement efficace, pour une période allant de 10 jours à une année ou plus.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intraocular drug delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraocular drug delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular drug delivery systems will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2086852

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.